NIH PAR · NCI · U54
PAR-28-062: Cancer Advancement through Partnerships in Research and Infrastructure (CAPRI) (U54 Clinical Trial Optional)
Reviewed by Dr. Meng ZhaoLast reviewed October 16, 2026Data refreshed October 16, 2026Editorial standards
This is a Notice of Funding Opportunity (NOFO) for a Limited Competition that invites applications from eligible organizations to apply. Please see Section III. Eligibility for additional information. In accordance with NIH standard peer-review processes, the applications will be peer-reviewed, and only meritorious applications will be considered for funding. This funding opportunity seeks to support the Cancer Advancement through Partnerships in Research and Infrastructure (CAPRI). The CAPRI Program establishes and strengthens comprehensive, mutually beneficial and meaningful partnerships between Resource Limited Institutions (RLIs) and NCI-designated Cancer Centers (CCs) to accelerate…
- NOFO number
- PAR-28-062
- Type
- PAR
- Activity code
- U54
- Primary institute
- NCI · National Cancer Institute
- Clinical trials
- Optional
- Posted
- Aug 31, 2026
- Opens
- Dec 25, 2026
- Expires
- Jan 26, 2027
PAR-28-062 due dates
1 application due date remains before the NOFO expires. Dates marked * are NIH standard due dates. Check the related notices below for changes NIH made after posting.
| New | Renewal / Resubmission / Revision (as allowed) | AIDS - New/Renewal/Resubmission/Revision, as allowed | Scientific Merit Review | Advisory Council Review | Earliest Start Date |
|---|---|---|---|---|---|
| January 25, 2027 * | January 25, 2027 * | Not Applicable | July 2027 | October 2027 | December 2027 |
What its predecessor PAR-22-249 funded
PAR-28-062 reissues PAR-22-249. Until awards appear under the new number, its funding history is the best guide to who wins under this program: 13 projects and $64.5M in FY2022–FY2026.
Projects funded
13
Distinct projects, FY2022–FY2026
New awards
4
Type 1 (new project) award records
NIH funding
$64.5M
Award dollars under PAR-22-249, FY2022–FY2026
Funding by fiscal year
| Fiscal year | Award records | New awards | Funding |
|---|---|---|---|
| FY2022 | 0 | 0 | $0 |
| FY2023 | 13 | 4 | $16.6M |
| FY2024 | 15 | 0 | $15.5M |
| FY2025 | 14 | 0 | $16.4M |
| FY2026 | 13 | 0 | $16.1M |
Institutions with the most funding
- Temple Univ of the Commonwealth$6.5M · 1 project
- Fred Hutchinson Cancer Center$5.5M · 1 project
- Beckman Research Institute/City of Hope$5.5M · 1 project
- H. Lee Moffitt Cancer Ctr & Res Inst$5.3M · 1 project
- Ponce School of Medicine$5.3M · 1 project
- University of California, San Diego$5.2M · 1 project
- University of California Riverside$5.1M · 1 project
- San Diego State University$4.9M · 1 project
Funding institutes
- NCI$64.5M · 55
Activity codes funded
- U5455 records
Most recent new awards
- 2/2 Drug Development and Capacity Building: A UCR/CoH-CCC Partnership (opens NIH RePORTER)
University of California Riverside · 1U54CA285114-01 · NCI · Notice Sep 22, 2023
$1.4MU54
- 1/2 Drug Development and Capacity Building: A UCR/CoH-CCC Partnership (opens NIH RePORTER)
Beckman Research Institute/City of Hope · 1U54CA285116-01 · NCI · Notice Sep 22, 2023
$1.4MU54
- 1/2 Cancer Research and Education to Advance HealTh Equity (CREATE) Partnership (opens NIH RePORTER)
San Diego State University · 1U54CA285117-01 · NCI · Notice Sep 19, 2023
$1.2MU54
- 2/2 Cancer Research and Education to Advance HealTh Equity (CREATE) Partnership (opens NIH RePORTER)
University of California, San Diego · 1U54CA285115-01 · NCI · Notice Sep 14, 2023
$1.3MU54
FY2026 closed on September 30, 2026, but NIH keeps posting that year's awards to RePORTER for several weeks. FY2026 figures reflect records available on October 16, 2026 and may rise slightly at the next refresh.
Participating institutes
2 NIH institutes and offices take applications under PAR-28-062. Contact the program officer at the institute that fits your research before applying.
- NCI · National Cancer Institute
- none
Related notices
Jan 23, 2026 · NOT-OD-26-031
NIH Pause on New Submissions to the NIH Human Embryonic Stem Cell Registry and Request for Information on Reducing Reliance on Human Embryonic Stem Cells in NIH-Supported Research.
Award terms
- Application types allowed
- New Renewal Resubmission The OER Glossary and the How to Apply - Application Guide provides details on these application types. Only those application types listed here are allowed for this NOFO.
- Award budget
- Application budgets are limited to 1.3 million in direct costs per year for partnerships of two institutions and 1.8 million in direct costs per year for partnerships of three institutions.
- Project period
- The maximum period is 5 years. NIH grants policies as described in the NIH Grants Policy Statement will apply to the applications submitted and awards made from this NOFO.
- Funds available and number of awards
- The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.
Summarized from the NOFO text; the full NOFO governs eligibility, budget, and review.
Related NOFOs
- Reissue of PAR-22-249.
Other open NOFOs for U54
About this page
GotGrant gathers the NOFO, its participation and change notices, and its NOSIs from the NIH Guide for Grants and Contracts, and counts funded projects from NIH RePORTER by the opportunity number each award was made under. Data refreshed October 16, 2026; the NIH Guide is the authoritative source. See our data methodology.